| | | 00615 | | 22.12.1998 | | GlaxoSmithKline AG | | | | | | | | | | | | | 08.08. | | | | 08.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Priorix | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | Lyophilisate and solvent (Virus Morbilli Vivus (Stamm Schwarz) 1000 U, Virus Parotitis Vivus (Stamm: rit 4385) 5000 U, Virus Rubella Vivus (Stamm Wistar ra 27/3) 1000 U) + () + () + () + () | J07BD52 | | | 02 | Priorix | | (Vaccinum Morbillorum Vivum 0 , Vaccinum Parotitidis Vivum 0 , Vaccinum Rubellae Vivum Attenuatum (Cellulae Hdc), Wistar ra 27/3 0 TC) | | | | 03 | Priorix | | (Vaccinum Morbillorum Vivum 0 , Vaccinum Parotitidis Vivum 0 , Virus Rubella Vivus (Stamm Wistar ra 27/3) 0 TC) | | |
|
|
